Results 61 to 70 of about 1,956 (168)

LZTR1 loss-of-function variants associated with café au lait macules with or without freckling

open access: yesFrontiers in Neurology
Pathogenic variants in the leucine zipper-like transcriptional regulator 1 gene (LZTR1) have been identified in schwannomatosis and Noonan syndrome. Here, we expand the phenotype spectrum of LZTR1 variants.
Svea Horn   +17 more
doaj   +1 more source

Comprehensive Genetic Analysis of NF2 in Sporadic Vestibular Schwannoma

open access: yesLaryngoscope Investigative Otolaryngology, Volume 10, Issue 5, October 2025.
Comprehensive genetic analyses, including whole‐exome sequencing, methylation analysis, and MLPA, are essential for accurately identifying NF2 inactivation mechanisms in sporadic vestibular schwannomas. The findings suggest that NF2 methylation may contribute to variations in clinical presentation.
Takeshi Wakabayashi   +14 more
wiley   +1 more source

Simple schwannomatosis or an incomplete Coffin-Siris? Report of a particular case

open access: yeseNeurologicalSci, 2019
Background: Schwannomatosis is a genetic disorder that belongs to NF family. The mutation of SMARCB1 gene has been related to this entity and Coffin-Siris syndrome, as well. We reported a case of a female patient with SMARCB1 mutation who has developed a
G. Bellantoni   +4 more
doaj   +1 more source

Visual outcome including visual field defects after treatment of paediatric optic pathway glioma: A nationwide cohort study

open access: yesActa Ophthalmologica, Volume 103, Issue 6, Page 662-673, September 2025.
Abstract Purpose To examine long‐term visual impairment and visual field examination (VF) after diverse treatments for paediatric optic pathway glioma (OPG), and to determine prognostic factors for long‐term severe visual impairment or blindness. Methods A nationwide retrospective cohort study (1995–2018) was performed on paediatric OPGs that received ...
C. A. M. Bennebroek   +13 more
wiley   +1 more source

Schwannomatosis: a genetic and epidemiological study

open access: yesJournal of Neurology, Neurosurgery & Psychiatry, 2018
ObjectivesSchwannomatosis is a dominantly inherited condition predisposing to schwannomas of mainly spinal and peripheral nerves with some diagnostic overlap with neurofibromatosis-2 (NF2), but the underlying epidemiology is poorly understood. We present the birth incidence and prevalence allowing for overlap with NF2.MethodsSchwannomatosis and NF2 ...
D Gareth Evans   +20 more
openaire   +4 more sources

NF2-related schwannomatosis and other schwannomatosis: an updated genetic and epidemiological study

open access: yesJournal of Medical Genetics
Objectives New diagnostic criteria for NF2-related schwannomatosis (NF2) were published in 2022. An updated UK prevalence was generated in accordance with these, with an emphasis on the rate of de novo NF2 (a 50% frequency is widely quoted in genetic counselling).
Claire Forde   +22 more
openaire   +4 more sources

Schwannomatosis [PDF]

open access: yesNeurology, 2008
Alexey, Surov   +2 more
openaire   +2 more sources

18F-FDG PET/CT revealed sporadic schwannomatosis involving the lumbar spinal canal and both lower limbs: a case report

open access: yesFrontiers in Medicine
Schwannomatosis is a rare autosomal dominant hereditary syndrome disease characterized by multiple schwannomas throughout the body, without bilateral vestibular schwannoma or dermal schwannoma.
Xiaotian Li   +4 more
doaj   +1 more source

ENDOSCOPIC TREATMENT OF THORACIC SCHWANNOMATOSIS: A CASE REPORT [PDF]

open access: yesColuna/Columna
Schwannomatosis, also known as neurofibromatosis type III, is a rare condition characterized by the development of multiple schwannomas along peripheral nerve sheaths.
Ramon Venzon Ferreira   +7 more
doaj   +2 more sources

Increasing access to specialty care for rare diseases: a case study using a foundation sponsored clinic network for patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis

open access: yesBMC Health Services Research, 2018
Background Our primary aim was to assess the ability of a non-profit foundation-sponsored clinic network to facilitate access to specialized care for patients with neurofibromatoses (NF), a group of neurogenetic disorders including NF1, NF2, and ...
Vanessa L. Merker   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy